BC
Boxer Capital Portfolio holdings
AUM
$2.04B
This Quarter Return
-22.56%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
–
AUM
$805M
AUM Growth
+$805M
(-11%)
Cap. Flow
+$128M
Cap. Flow
% of AUM
15.86%
Top 10 Holdings %
Top 10 Hldgs %
80.9%
Holding
29
New
5
Increased
6
Reduced
4
Closed
6
Top Buys
| 1 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$60.5M |
| 2 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$37.9M |
| 3 |
uniQure
QURE
|
$34.6M |
| 4 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$28.7M |
| 5 |
DBVT
DBV Technologies
DBVT
|
$19.3M |
Top Sells
| 1 |
Kiniksa Pharmaceuticals
KNSA
|
$24.8M |
| 2 |
MDCO
Medicines Co
MDCO
|
$22.4M |
| 3 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$19.6M |
| 4 |
Esperion Therapeutics
ESPR
|
$8.05M |
| 5 |
Rigel Pharmaceuticals
RIGL
|
$7.45M |
Sector Composition
| 1 | Healthcare | 97.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RGLS
26
DELISTED
Regulus Therapeutics
RGLS
| – | – |
-1,697,802
| Closed | -$4.03M |
|
|
27
Rigel Pharmaceuticals
RIGL
$690M
| – | – |
-2,321,900
| Closed | -$7.45M |
|
28
Syndax Pharmaceuticals
SNDX
$1.39B
| – | – |
-100,000
| Closed | -$808K |
|
29
Xenon Pharmaceuticals
XENE
$3.03B
| – | – |
-300,000
| Closed | -$3.96M |
|